SAR-440234

N/A

Report date: 2026/03/19 16:46:33

Base Information

Drug NameSAR-440234

Drug Alias NameSAR-440234

ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Multispecific monoclonal antibody > Bispecific monoclonal antibodyBiologics > T cell engagers

Mechanisms of ActionAnti-CD3Anti-CD123

TargetsT cell surface glycoprotein CD3Interleukin-3 receptor subunit alpha

Therapy Area/IndicationsLeukemia

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited StatesFrance

CombinationsNo

Global Highest StatusDiscontinued (Phase 2 Clinical)

Highest Status in ChinaN/A

Originator CompaniesSanofi

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesSanofi

Active IndicationsN/A

Inactive IndicationsLeukemia

Other Information

ATC CodeN/A